These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33671590)

  • 1. Development of Genome Editing Approaches against Herpes Simplex Virus Infections.
    Zhang I; Hsiao Z; Liu F
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
    van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
    PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
    Chen YC; Sheng J; Trang P; Liu F
    Viruses; 2018 May; 10(6):. PubMed ID: 29844277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9.
    Oh HS; Neuhausser WM; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
    Elife; 2019 Dec; 8():. PubMed ID: 31789594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting NECTIN-1 Based on CRISPR/Cas9 System Attenuated the Herpes Simplex Virus Infection in Human Corneal Epithelial Cells In Vitro.
    Li Y; Wei Y; Li G; Huang S; Xu J; Ding Q; Hong J
    Transl Vis Sci Technol; 2022 Feb; 11(2):8. PubMed ID: 35119473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
    Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors.
    Khodadad N; Fani M; Jamehdor S; Nahidsamiei R; Makvandi M; Kaboli S; Teimoori A; Thekkiniath J
    Folia Histochem Cytobiol; 2020; 58(3):174-181. PubMed ID: 32937678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-Based Genome Editing of HSV.
    Velusamy T; Gowripalan A; Tscharke DC
    Methods Mol Biol; 2020; 2060():169-183. PubMed ID: 31617178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research.
    Wang D; Wang XW; Peng XC; Xiang Y; Song SB; Wang YY; Chen L; Xin VW; Lyu YN; Ji J; Ma ZW; Li CB; Xin HW
    Cancer Gene Ther; 2018 Jun; 25(5-6):93-105. PubMed ID: 29691470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection.
    Wang J; Quake SR
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13157-62. PubMed ID: 25157128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HSV-1 Replication by Gene Editing Strategy.
    Roehm PC; Shekarabi M; Wollebo HS; Bellizzi A; He L; Salkind J; Khalili K
    Sci Rep; 2016 Apr; 6():23146. PubMed ID: 27064617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo CRISPR gene editing in patients with herpetic stromal keratitis.
    Wei A; Yin D; Zhai Z; Ling S; Le H; Tian L; Xu J; Paludan SR; Cai Y; Hong J
    Mol Ther; 2023 Nov; 31(11):3163-3175. PubMed ID: 37658603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivo.
    Aubert M; Haick AK; Strongin DE; Klouser LM; Loprieno MA; Stensland L; Santo TK; Huang ML; Hyrien O; Stone D; Jerome KR
    Nat Commun; 2024 May; 15(1):4018. PubMed ID: 38740820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes Simplex Virus 1 Manipulates Host Cell Antiviral and Proviral DNA Damage Responses.
    Mertens ME; Knipe DM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene editing and elimination of latent herpes simplex virus in vivo.
    Aubert M; Strongin DE; Roychoudhury P; Loprieno MA; Haick AK; Klouser LM; Stensland L; Huang ML; Makhsous N; Tait A; De Silva Feelixge HS; Galetto R; Duchateau P; Greninger AL; Stone D; Jerome KR
    Nat Commun; 2020 Aug; 11(1):4148. PubMed ID: 32811834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
    Yin LJ; Hu SQ; Guo F
    Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral DNA Sensors IFI16 and Cyclic GMP-AMP Synthase Possess Distinct Functions in Regulating Viral Gene Expression, Immune Defenses, and Apoptotic Responses during Herpesvirus Infection.
    Diner BA; Lum KK; Toettcher JE; Cristea IM
    mBio; 2016 Nov; 7(6):. PubMed ID: 27935834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSV-1 tegument protein and the development of its genome editing technology.
    Xu X; Che Y; Li Q
    Virol J; 2016 Jun; 13():108. PubMed ID: 27343062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.